According to ISO 10993-18, ISO 10993-12 and ISO 10993-17**
Extractables: Compounds that can be released from a medical device under exaggerated laboratory conditions.
Leachables: Compounds that migrate into the patient or clinical environment under actual usage conditions.
VOC (Volatile Organic Compounds) and SVOC (Semi-Volatile Organic Compounds) are the main chemical groups of concern.
Process steps include:
✔ Material characterization
✔ Determination of extractables and leachables
✔ GC-MS analysis of VOC profiles
✔ AET calculation (Analytical Evaluation Threshold)
| Device Type | Surface/Volume Ratio | Temperature | Duration |
|---|---|---|---|
| Implant devices | 6 cm²/mL | 37°C | 72 h |
| Parenteral use | 3 cm²/mL | 50°C | 24 h |
| Surface devices | 1 cm²/mL | 37°C | 24 h |
PDE determination
Exposure dose calculation
Margin of Safety:
A MOS equal to or above 1 indicates safety.
| Method | Target Compounds | Benefit |
|---|---|---|
| HS-GC-MS | VOC | Solvent-free |
| SPME-GC-MS | VOC & SVOC | High sensitivity |
| GC-FID | Total VOC | Quantitative |
| LC-MS/MS | Non-volatile polar compounds | Advanced profiling |
✔ ISO 10993-18 compliant chemical characterization
✔ ISO 10993-12 extraction protocols
✔ GC-MS / LC-MS/MS / Headspace analysis
✔ Toxicological assessment according to ISO 10993-17
✔ MDR, FDA, ISO 13485 compliant documentation